/ TerminatedNot Applicable Clinical Evaluation of a SARS-CoV-2 CoviDx™COVID-19 Antigen Self-Test
Prospective study that will evaluate the clinical agreement of the CoviDx™ Self test compared to SARS-CoV-2 RT-PCR.
/ CompletedNot Applicable Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 CoviDx™ Rapid Antigen Test
Prospective study that will evaluate the clinical agreement of the CoviDx™ Rapid Antigen test compared to SARS-CoV-2 RT-PCR.
/ CompletedNot Applicable Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Prospective, multi-center, observational, blinded clinical trial to compare a new point of care (POC) SARS-CoV-2 IgG antibody test to a reference SARS-CoV-2 PCR test using fingerstick whole blood.
100 Clinical Results associated with Rapid Pathogen Screening, Inc.
0 Patents (Medical) associated with Rapid Pathogen Screening, Inc.
26 Nov 2018·Open Forum Infectious Diseases
2023. A Prospective, Multi-Center U.S. Clinical Trial to Determine Accuracy of FebriDx Point-of-Care Testing for Acute Upper Respiratory Infections with and Without a Confirmed Fever
Author: Sharp, Stephan ; Rosen, Jeffrey ; Sambursky, Robert ; Shapiro, Nathan ; Parekh, Amisha ; Self, Wesley ; Kurz, Michael ; Hou, Peter ; Filbin, Michael
01 Dec 2016·Open Forum Infectious Diseases
Rhinovirus, Influenza A, and Influenza B, and Their Impact on Myxovirus Resistance Protein A, Procalcitonin, and C-Reactive Protein Biomarkers
Author: Sambursky, Robert ; Shapiro, Nathan
01 Dec 2014·Open Forum Infectious Diseases
1358Evaluating the Accuracy of Combining two Biomarkers to Differentiate Viral and/or Bacterial Immune Response in Patients with Acute Febrile Respiratory Infection
Author: Sambursky, Robert ; Shapiro, Nathan
100 Deals associated with Rapid Pathogen Screening, Inc.
100 Translational Medicine associated with Rapid Pathogen Screening, Inc.